Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Skryabin, V Yu
748  Ergebnisse:
Personensuche X
?
1

Effects of CYP2C19 genetic polymorphism on the steady-state..:

Zastrozhin, M. S. ; Skryabin, V. Yu ; Petukhov, A. E....
The Pharmacogenomics Journal.  21 (2021)  4 - p. 435-439 , 2021
Link: https://doi.org/10.1038/..
 
?
2

Effects of plasma concentration of micro-RNA Mir-27b and CY..:

Zastrozhin, M.S. ; Skryabin, V.Yu. ; Smirnov, V.V....
Gene.  739 (2020)  - p. 144513 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Pharmacogenetics of alcohol addiction: current perspectives:

Zastrozhin, M.S. ; Skryabin, V.Yu ; Miroshkin, S. S...
The Application of Clinical Genetics.  12 (2019)  - p. 131-140 , 2019
Link: https://doi.org/10.2147/..
 
?
4

U–Pb zircon geochronology and geochemistry of Paleoproteroz..:

Terentiev, R.A. ; Skryabin, V.Yu. ; Santosh, M.
Precambrian Research.  273 (2016)  - p. 165-184 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Cambrian magmatic activation of the East European Platform:

Skryabin, V. Yu. ; Savko, K. A. ; Skryabin, M. V..
Doklady Earth Sciences.  463 (2015)  2 - p. 822-827 , 2015
Link: https://doi.org/10.1134/..
 
?
6

Trondhjemite-granodiorite intrusive magmatism of the Losevo..:

Skryabin, V. Yu. ; Terentiev, R. A.
Doklady Earth Sciences.  458 (2014)  2 - p. 1261-1264 , 2014
Link: https://doi.org/10.1134/..
 
?
7

Adverse drug reactions of macrolide therapy: analysis of sp..:

Skryabina A.A ; Nikiforov V.V ; Shakhmardanov M.Z...
https://cmac-journal.ru/publication/2023/1/cmac-2023-t25-n1-p34/cmac-2023-t25-n1-p34.pdf.  , 2023
Link: https://doi.org/10.36488..
 
?
8

Pharmacogenetics of alcohol addiction: current perspectives:

Zastrozhin, M.S ; Skryabin, V.Yu ; Miroshkin, S. S..
info:eu-repo/semantics/altIdentifier/doi/10.2147/TACG.S206745.  , 2019
Link: https://www.dovepress.co..
 
?
9

Pharmacogenetics of alcohol addiction: current perspectives:

Zastrozhin, M S ; Skryabin, V Yu ; Miroshkin, S S..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628972/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
10

Using the CYP3A Activity Evaluation to Predict the Efficacy..:

Skryabin, Valentin Yu. ; Zastrozhin, Mikhail S. ; Grishina, Elena A....
Journal of Pharmacy Practice.  35 (2021)  4 - p. 518-523 , 2021
Link: https://doi.org/10.1177/..
 
?
11

Polymorphism 3435c> t of the ABCB1 gene (rs1045642) does no..:

M. Zastrozhin S ; E. Grishina A ; K. Ryzhikova A...
https://bulletin.tomsk.ru/jour/article/view/4152/2872.  , 2021
Link: https://bulletin.tomsk.r..
 
?
12

MicroRNA hsa-miR-370-3p is a new biomarker for assessing th..:

M. Zastrozhin S ; V. Skryabin Yu ; E. Grishina A...
https://www.medgen-journal.ru/jour/article/view/1738/1374.  , 2020
Link: https://www.medgen-journ..
 
?
13

Effects of CYP2D6 gene polymorphism 1846G>A on lexotan effi..:

F. Zakirov Kh ; M. Zastrozhin S ; V. Smirnov V...
https://www.medgen-journal.ru/jour/article/view/1737/1373.  , 2020
Link: https://www.medgen-journ..
 
?
14

Expirience of implementation of personalized clinical decis..:

M. Zastrozhin S ; A. Sorokin S ; T. Agibalova V...
https://www.medgen-journal.ru/jour/article/view/621/397.  , 2019
Link: https://www.medgen-journ..
 
?
15

The influence of plasma treatment on the change of elementa..:

Lavrinenko, V. I. ; Sytnyk, B. V. ; Skryabin, V. O....
Journal of Superhard Materials.  32 (2010)  4 - p. 270-273 , 2010
Link: https://doi.org/10.3103/..
 
1-15